Dementia, Alzheimer Type Completed Phase 3 Trials for Rivastigmine (DB00989)

Also known as: Alzheimer Type Dementia / Alzheimer's Type Dementia

IndicationStatusPhase
DBCOND0030656 (Dementia, Alzheimer Type)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00099242Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseTreatment